Century Therapeutics Inc
IPSC
$1.50+8.70%
End of day · as of Oct 16, 2026, 8:01 AM ET
Mkt cap
$47.83M
EV/Sales
N/A
P/E ratio
N/A
Revenue (qtr ended 2025-09-30)
$109.16M
EPS (H1 2026)
$-0.28
Gross Margin (qtr ended 2025-09-30)
N/A
Profit Margin (qtr ended 2025-09-30)
8.79%
Beta
1.77
Div yield
N/A
Sector
Healthcare
Century Therapeutics Inc (IPSC) is a biotechnology company listed on US.
Latest reported IPSC revenue for 2025-09-30 was $109.2M. Net income was $9.6M. Revenue was up 0.0% from 2025-06-30 to 2025-09-30. IPSC currently screens at market cap $47.8M.
Use this IPSC research hub for sector, financials, and filings — not a live tape.
Each line names its own latest cached period. Full IPSC income, balance, and cash tables.
Century Therapeutics Inc (IPSC) is a biotechnology company in the Healthcare sector.
Latest cached Century Therapeutics Inc (IPSC) revenue for Sep 30, 2025 was $109.2M. Net income was $9.6M. Statements: https://lician.com/financials/ipsc
Century Therapeutics Inc (IPSC) market capitalization is $47.8M on the latest cached snapshot.
Century Therapeutics Inc (IPSC) cached previous close $1.38; day range $1.38 – $1.51; volume 926,494. Session quote: https://lician.com/quote/ipsc
Century Therapeutics Inc (IPSC) latest cached earnings event is "IPSC earnings" on Aug 13, 2026. Earnings calendar: https://lician.com/earnings
The latest cached IPSC filing is 8-K · Oct 2, 2026. Filings: https://lician.com/sec/ipsc